复杂而危险的过程中,与异质毒素相关的先天性心脏病
Anna Olds1,2, James M Meza1,2, Nithya Rajeev1
1Division of Cardiothoracic Surgery, Department of Surgery, University of Southern California, Los Angeles, Calif.
JTCVS open
|September 9, 2025
概括
与异质氧相关的先天性心脏病 (CHD) 手术具有很高的风险. 死亡/移植的关键预测因素包括缩,全异常肺静脉回归修复,三动脉缩和Fontan或心房膜再干预.
科学领域:
- 心脏病学 心脏病学
- 儿科心脏手术 儿科心脏手术
- 遗传性心脏病是一种先天性心脏病.
背景情况:
- 与异质氧相关的先天性心脏病 (CHD) 通常需要复杂的多阶段手术干预.
- 了解纵向风险因素对于改善这些高风险患者的治疗结果至关重要.
研究的目的:
- 为了确定心脏手术的过程,在一个大队列的患者与异质毒素相关的CHD.
- 识别与死亡或需要心脏移植相关的纵向风险因素.
主要方法:
- 对217名经过心脏手术 (2005-2022) 的异质氧相关性CHD患者进行了回顾性审查.
- 人口统计,心脏解剖学和手术过程的分析.
- 参数危险分析,将操作视为时间变化的共变量,以确定死亡/移植的风险因素.
主要成果:
- 在1,5年和10年的无移植生存率分别为79.4%,71.0%和63.9%.
- 早期阶段的危险因素包括缩和全异常肺静脉回归 (TAPVR) 修复与肺血流控制.
- 后期阶段的危险因素包括三形缩,Fontan修订和心房膜再干预. 格伦手术降低了风险.
结论:
- 异质毒素相关性CHD的手术治疗与显著的风险有关,特别是TAPVR修复.
- 婴儿期后的风险在很大程度上取决于需要Fontan息或心房膜再操作的需要.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
416
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
416
Cardiomyopathy IV: Restrictive Cardiomyopathy
472
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
472
Mitral Stenosis I: Introduction
485
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
485
Cardiomyopathy II: Dilated Cardiomyopathy
480
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
480
Cardiomyopathy V: Interprofessional Care
343
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
343
Cardiomyopathy I: Introduction and Classification
514
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
514


